These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26963573)

  • 1. Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting System.
    Pomeranz HD
    J Neuroophthalmol; 2016 Jun; 36(2):221-2. PubMed ID: 26963573
    [No Abstract]   [Full Text] [Related]  

  • 2. Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy.
    Lee AG; Newman NJ
    Am J Ophthalmol; 2005 Oct; 140(4):707-8. PubMed ID: 16226524
    [No Abstract]   [Full Text] [Related]  

  • 3. Are Erectile Dysfunction Medications Causally Related to Nonarteritic Anterior Ischemic Optic Neuropathy?
    Lee MS; Vaphiades M
    J Neuroophthalmol; 2016 Jun; 36(2):202-7. PubMed ID: 26828844
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonarteritic Anterior Ischemic Optic Neuropathy and Erectile Dysfunction Drugs: Is There an Elephant in the Bedroom?
    Kruger JM; Pomeranz HD
    J Neuroophthalmol; 2017 Mar; 37(1):104-105. PubMed ID: 27984350
    [No Abstract]   [Full Text] [Related]  

  • 5. [Non-arteritic anterior ischemic optic neuropathy associated with erectile dysfunction medications].
    Krashin-Bichler I; Dotan G
    Harefuah; 2013 Feb; 152(2):84-7, 123. PubMed ID: 23513498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual side effects associated with erectile dysfunction agents.
    Fraunfelder FW
    Am J Ophthalmol; 2005 Oct; 140(4):723-4. PubMed ID: 16226525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic aspects of erectile dysfunction drugs.
    Verit A; Oguz H
    Am J Ophthalmol; 2006 Mar; 141(3):598; author reply 599. PubMed ID: 16490529
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of nonarteritic ischaemic optic neuropathy with phosphodiesterase type 5 inhibitors: a systematic review and meta-analysis.
    Penedones A; Alves C; Batel Marques F
    Acta Ophthalmol; 2020 Feb; 98(1):22-31. PubMed ID: 31559705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitors.
    Campbell UB; Walker AM; Gaffney M; Petronis KR; Creanga D; Quinn S; Klein BE; Laties AM; Lewis M; Sharlip ID; Kolitsopoulos F; Klee BJ; Mo J; Reynolds RF
    J Sex Med; 2015 Jan; 12(1):139-51. PubMed ID: 25358826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship Between Phosphodiesterase-5 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy.
    Pomeranz HD
    J Neuroophthalmol; 2016 Jun; 36(2):193-6. PubMed ID: 26720519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avanafil (Stendra)--another PDE5 inhibitor for erectile dysfunction.
    Med Lett Drugs Ther; 2014 May; 56(1442):37-8. PubMed ID: 24818838
    [No Abstract]   [Full Text] [Related]  

  • 12. Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature.
    Azzouni F; Abu samra K
    J Sex Med; 2011 Oct; 8(10):2894-903. PubMed ID: 21771280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erectile Dysfunction Agents and Nonarteritic Anterior Ischemic Optic Neuropathy.
    Pomeranz HD
    Neurol Clin; 2017 Feb; 35(1):17-27. PubMed ID: 27886893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use.
    Li AS; Pomeranz HD
    J Neuroophthalmol; 2016 Dec; 36(4):480-481. PubMed ID: 27851718
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of erectile dysfunction drugs on eyes.
    Yang H; Gu X; Zhang X; Yi C
    Eye Sci; 2011 Jun; 26(2):115-20. PubMed ID: 21692212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approves new ED remedy.
    Traynor K
    Am J Health Syst Pharm; 2012 Jun; 69(11):906. PubMed ID: 22610014
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link?
    Hatzimouratidis K
    Curr Urol Rep; 2007 Nov; 8(6):482-90. PubMed ID: 18042329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Case-crossover Study Investigating the Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy and Phosphodiesterase Type 5 Inhibitor Exposure.
    Flahavan EM; Li H; Gupte-Singh K; Rizk RT; Ruff DD; Francis JL; Kinchen KS
    Urology; 2017 Jul; 105():76-84. PubMed ID: 28336289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-arteritic anterior ischemic optic neuropathy (NAION) and phosphodiesterase type-5 inhibitors.
    Bella AJ; Brant WO; Lue TF; Brock GB
    Can J Urol; 2006 Oct; 13(5):3233-8. PubMed ID: 17076943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction.
    Thurtell MJ; Tomsak RL
    Int J Impot Res; 2008; 20(6):537-43. PubMed ID: 18528398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.